Candida albicans sterol C-14 reductase, encoded by the ERG24 gene, as a potential antifungal target site

Antimicrobial Agents and Chemotherapy

Volumn 46, Issue 4, 2002, Pages 947-957

  Jia, N ^a   Arthington Skaggs, B ^a   Lee, W ^a   Pierson, C A ^a   Lees, N D ^a   Eckstein, J ^a   Barbuch, R ^a   Bard, M ^a  

^a INDIANA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; BREFELDIN A; CERULETIDE; CLOTRIMAZOLE; CYCLOHEXIMIDE; DNA; ERGOSTEROL; FENPROPIMORPH; FLUCONAZOLE; FLUPHENAZINE; FUNGAL ENZYME; ITRACONAZOLE; KETOCONAZOLE; LANOSTEROL; MORPHOLINE DERIVATIVE; NYSTATIN; STEROL; STEROL C 14 REDUCTASE; TERBINAFINE; TRIDEMORPH; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA; CANDIDA ALBICANS; DNA SEQUENCE; DRUG TARGETING; FUNGUS MUTANT; GENE OVEREXPRESSION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SACCHAROMYCES CEREVISIAE;

AMINO ACID SEQUENCE; ANIMALS; ANTIFUNGAL AGENTS; CALCIUM; CANDIDA ALBICANS; CANDIDIASIS; CULTURE MEDIA; DNA PROBES; DNA, FUNGAL; ESCHERICHIA COLI; FEMALE; GENE LIBRARY; GENES, FUNGAL; MICE; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; OXIDOREDUCTASES; PHENOTYPE; PLASMIDS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STEROLS; TRANSFORMATION, BACTERIAL;

EID: 0036208623     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.46.4.947-957.2002     Document Type: Article

References (37)

1. Inhibition of sterol 8-7 isomerase and14-reductase by fenpropimorph, tridemorph, and fenpropidin in cell-free enzyme systems from Saccharomyces cerevisiae
2. Differences in crystal violet dye uptake and cation-induced death among yeast sterol mutants
3. Sterol synthesis and viability of erg11 (cytochrome P-450 lanosterol demethylase) mutations in Saccharomyces cerevisiae and Candida albicans
4. The effect of the erg26-1 mutation on the regulation of lipid metabolism in Saccharomyces cerevisiae
5. Thirteen-year evolution of azole resistant yeast isolates and prevalence of resistant strains carried by cancer patients at a large medical center
6. Amphotericin B: Current understanding of mechanism of action
7. Stable transformation and regulated expression of an inducible reporter construct in Candida albicans using restriction enzyme-mediated integration
8. A novel multidrug efflux transporter gene of the major facilitator superfamily from Candida albicans (FLU1) conferring resistance to fluconazole
9. Aerobic isolation of an ERG24 null mutant of Saccharomyces cerevisiae
10. A calcium-dependent ergosterol mutant of Saccharomyces cerevisiae
11. Isogenic strain construction and gene mapping in Candida albicans
12. Human mycoses: Drugs and targets for emerging pathogens
13. Effect of anti-calmodulin drugs on the growth and sensitivity of C6 rat glioma cells to bleomycin
14. Biochemical and genetic characterization of Rbflp, a putative transcription factor of Candida albicans
15. The gene encoding squalene epoxidase from Saccharomyces cerevisiae: Cloning and characterization
16. A critical role of sterols in embryonic patterning and meristem programming revealed by the fackel mutants of Arabidopsis thaliana
17. Sequencing, disruption, and characterization of the Candida albicans sterol methyltransferase (ERG6) gene: Drug susceptibility studies in erg6 mutants
18. Genetic analysis of azole resistance in the Darlington strain of Candida albicans
19. ESR determination of membrane permeability in a yeast sterol mutant
20. Identification of a gene family in the Saccharomyces cerevisiae ergosterol biosynthesis pathway
21. Cloning, sequencing and disruption of the gene encoding the C-14 sterol reductase in Saccharomyces cerevisiae
22. Construction and growth properties of a yeast strain defective in sterol 14-reductase
23. Polyene resistance and the isolation of sterol mutants in Saccharomyces cerevisiae
24. Effect of side-chain structure on inhibition of yeast fatty acid synthase by cerulenin analogues
25. ELO2 and ELO3, homologues of the Saccharomyces cerevisiae ELO1 gene, function in fatty acid elongation and are required for sphingolipid formation
26. Amphotericin B-resistant yeast infection in severely immunocompromised patients
27. Cloning of Candida albicans genes conferring resistance to azole antifungal agents: Characterization of CDR2, a new multidrug ABC transporter gene
28. A system of shuttle vectors and yeast host strains designated for efficient manipulation of DNA in Saccharomyces cerevisiae
29. The immunosuppressant SR31747 blocks cell proliferation by inhibiting a steroid isomerase in Saccharomyces cerevisiae
30. Anti-Candida drugs - The biochemical basis for their activity
31. Brefeldin A causes a defect in secretion in Saccharomyces cerevisiae
32. New targets and delivery systems for antifungal therapy
33. Mutations in the LIS1 (ERG6) gene confer increased sodium and lithium uptake in Saccharomyces cerevisiae
34. Increased mRNA levels of ERG16, CDR, and MDR1 correlate with increases in azole resistance in Candida albicans isolates from a patient infected with human immunodeficiency virus
35. The presence of an R467K amino acid substitution and loss of allelic variation correlates with an azole-resistant lanosterol 14-alpha-demethylase in Candida albicans
36. Rapid hypothesis testing with Candida albicans through gene disruption with short homology regions